381 results on '"McAlpine, Jessica N."'
Search Results
2. VOLTA: an enVironment-aware cOntrastive ceLl represenTation leArning for histopathology
3. Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive Analysis
4. Complications after opportunistic salpingectomy compared with tubal ligation at cesarean section: a retrospective cohort study
5. p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer: Does Null Pattern Correlate With Prognosis?
6. Harmonized molecular classification; assessment of a single-test ProMisE NGS tool
7. Single-cell genomic variation induced by mutational processes in cancer
8. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
9. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
10. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach
11. BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
12. Endometrial cancer
13. Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol
14. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome
15. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
16. The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile.
17. Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique
18. Endometrial Carcinoma Molecular Subtype Correlates With the Presence of Lymph Node Metastases
19. Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion.
20. p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns
21. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status
22. Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification
23. Therapeutic options for mucinous ovarian carcinoma
24. From biobank and data silos into a data commons: convergence to support translational medicine
25. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics
26. Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling
27. Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer
28. Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma
29. FIGO 2023 endometrial cancer staging: too much, too soon?
30. Improving response to progestin treatment of low-grade endometrial cancer
31. Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.
32. Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers
33. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma
34. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
35. L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
36. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
37. Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
38. Canadian high risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high risk endometrial cancers
39. Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada
40. The molecular origin and taxonomy of mucinous ovarian carcinoma
41. Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
42. Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
43. Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study
44. Clinical and pathological characterization of endometrial cancer in young women: Identification of a cohort without classical risk factors
45. Corrigendum to “Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death”: [Modern Pathology 36 (2023) 100085]
46. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
47. Determinants of Quality of Life in Ovarian Cancer Survivors: A Pilot Study
48. The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift
49. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
50. Changing Clinical Practice: Evaluation of Implementing Recommendations for Opportunistic Salpingectomy in British Columbia and Ontario
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.